Akari Therapeutics (AKTX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akari Therapeutics

    NASDAQ: AKTX · Real-Time Price · USD
    0.69
    -0.04 (-5.48%)
    At close: Sep 04, 2025, 3:57 PM

    Akari Therapeutics Revenue

    Akari Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Akari Therapeutics generated $0 in revenue.
    Revenue (ttm)
    0
    Revenue Growth
    n/a
    Price / Sales Ratio
    0
    Revenue / Employee
    0
    Employees
    8
    Market Cap
    11.25K

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Dec 31, 2023 0 n/a
    Dec 31, 2022 0 n/a
    Dec 31, 2021 0 n/a
    Dec 31, 2020 0 n/a
    Dec 31, 2019 0 n/a
    Dec 31, 2018 0 n/a
    Dec 31, 2017 0 n/a
    Dec 31, 2016 0 n/a
    Dec 31, 2015 0 n/a
    Dec 31, 2014 0 n/a
    Dec 31, 2013 0 n/a
    Dec 31, 2012 0 n/a
    Dec 31, 2011 0 n/a
    Dec 31, 2010 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist